Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941

Although advances in diagnostics and therapeutics have prolonged the survival of triple-negative breast cancer (TNBC) patients, metastasis, therapeutic resistance, and lack of targeted therapies remain the foremost hurdle in the effective management of TNBC. Thus, evaluation of new therapeutic agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehraj, Umar, Wani, Nissar Ahmad, Hamid, Abid, Alkhanani, Mustfa, Almilaibary, Abdullah, Mir, Manzoor Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393306/
https://www.ncbi.nlm.nih.gov/pubmed/36003501
http://dx.doi.org/10.3389/fphar.2022.958443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393306/
https://www.ncbi.nlm.nih.gov/pubmed/36003501
http://dx.doi.org/10.3389/fphar.2022.958443

Ejemplares similares